Wed01272021

Last updateWed, 13 Jan 2021 10am

Back You are here: Inicio Biology & biomedicine Technological offers

Silencing a gene makes a plant resistant to several viral diseases

Plants injected with virus. Left, a non resistant plant. Right, a resistant plant. Picture: CSIC. CSIC scientists at the the Centro de Edafología y Biología Aplicada del Segura (CEBAS) have developed a method to generate varieties of cucurbits (which includes species such as melon, cucumber, watermelon or pumpkins) resistant to several viral diseases. The method is based on silencing a gene of the plant wich expresses a protein used by the virus for its own replication and spreading of the infection. No foreign elements are introduced, which reduces the chance of unexpected repercussions.

Contact:

Vicepresidencia Adjunta
de Transferencia del Conocimiento /CEBAS - CSIC
Yolanda Hernando
Tel. +(34) 968 39 63 56
This email address is being protected from spambots. You need JavaScript enabled to view it.

Read more ...

Derivates of resveratrol to treat inflammatory bowel disease

Scientists from the CSIC have designed a group of anti-inflammatory compounds, derivates of resveratrol, which  have been patented. An experiment to test the new molecules against ulcerative colitis has shown that they are effective in very small quantities.

 

Read more ...

Modified cells from patient to treat ischemia

A group of researchers from the CSIC has developed a new cell therapy that could treat ischemia and renal failure.

Read more ...

Neuroprotective molecules to treat Alzheimer and Parkinson

Researchers from the CSIC and two spanish universities have developed new propargylamine derivatives for the treatment of neurodegenerative diseases, particularly Alzheimer's.

Read more ...

The CSIC has obtained the designation of raloxifene as an orphan drug

The Spanish National Research Council (Consejo Superior de Investigaciones Científicas, CSIC), in collaboration with the Institute for Training and Research Marqués de Valdecilla, has obtained the designation of raloxifene (a drug used for osteoporosis during menopause) as an orphan drug.

Read more ...